StockPriceToday
Marriott International Inc (MAR)
About Marriott International Inc
Marriott International Inc. operates as a leading hospitality company that manages, franchises, and licenses hotel, residential, and timeshare properties worldwide under numerous brand names. The company's global hotel presence has made MAR stock price highly sensitive to travel demand, economic conditions, and tourism industry trends.
Marriott's brand portfolio includes luxury brands like The Ritz-Carlton and St. Regis, premium brands like Marriott Hotels and Sheraton, and select-service brands like Courtyard and Fairfield Inn. The company's properties serve business and leisure travelers across various price points and market segments.
The company's Bonvoy loyalty program and direct booking initiatives help reduce distribution costs while enhancing customer retention. Marriott's expansion into alternative accommodations and extended-stay properties demonstrates its adaptation to changing travel preferences, affecting MAR stock price movements.
Marriott's asset-light business model generates fee revenue from management and franchise agreements while providing global scale advantages. The company's ability to adapt to changing travel patterns while maintaining brand strength remains important for its continued success and market leadership.
MAR Stock 12 Month Chart
Latest News for MAR
Marriott International, Inc. (Nasdaq: MAR) today announced that its board of directors declared a quarterly cash dividend of 73 cents per share of common stock, which reflects the company's earnings ...
This was the stock's second consecutive day of gains.
MAR is slated to report Q1 2026 results on May 6, with EPS seen up 12% and RevPAR guided +1-2% as leisure and international demand lead.
Other Popular Stocks
Seagate Technology Holdings PLC (STX) is a leading global provider of data storage solutions, manufacturing hard disk drives and solid-state drives for consumer electronics,...
Mercury Systems Inc (MRCY) is a defense technology company providing mission-critical electronic systems and components for aerospace, defense, and intelligence applications.
Mineralys Therapeutics Inc. (MLYS) is a biotechnology company developing therapies for hypertension and other cardiovascular conditions using novel therapeutic approaches.